CompaniesInova Diagnostics

Inova Diagnostics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

1

As Collaborator

4

Total Enrollment

629

By Phase

EARLY_PHASE1: 1PHASE4: 1

By Status

COMPLETED: 2UNKNOWN: 1WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details

Recent Trials

NCT03843658Collaborator
Identifying Novel Biomarkers in Early Rheumatology Patients
N/AUnknown
300 participants
Started: Mar 15, 2019 · Completed: Sep 15, 2020
NCT03420976Collaborator
Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth
EARLY_PHASE1Withdrawn
Started: Dec 7, 2017 · Completed: Feb 1, 2019
NCT03051204Collaborator
OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome
N/ACompleted
175 participants
Started: Feb 28, 2017 · Completed: Dec 11, 2018
NCT02403297Lead Sponsor
Rapid Point-of-Care Salivary Diagnostic for Periodontal Health
N/ATerminated
93 participants
Started: Mar 31, 2015 · Completed: May 31, 2016
NCT01641341Collaborator
Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
PHASE4Completed
61 participants
Started: Nov 30, 2010 · Completed: Mar 31, 2012
Related Companies
Werfen
acquired